GlassScriptPhysician profile
Jeffrey A Fowler
NPI 1497998090
$26,417.25
in general payments reported to CMS, 2019-2025
27 companies · $8,734 in 2025
The $8,734 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,487 · 2020: $2,852 · 2021: $1,096 · 2022: $1,792 · 2023: $4,173 · 2024: $5,284 · 2025: $8,734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $4,183 · Consulting Fee: $2,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,632.06 |
| Travel and Lodging | $4,182.90 |
| Consulting Fee | $2,375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,317.17 | 2019-2025 | Navitor, Mitraclip, Ultreon |
| Edwards Lifesciences Corporation | $4,250.33 | 2022-2025 | Evoque, Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $3,374.86 | 2019-2025 | Impella |
| Boston Scientific Corporation | $2,325.46 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Watchman |
| Medtronic, INC. | $951.66 | 2022-2025 | Corevalve Evolut R, Arctic Front Advance |
| Shockwave Medical, INC | $928.32 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Inari Medical, INC. | $383.35 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $244.48 | 2023-2025 | Repatha, Repatha |
| Stryker Corporation | $205.85 | 2024-2025 | Flowtriever, Lifepak 35, Flowtriever Catheter, S |
| Recor Medical INC | $193.09 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Acist Medical Systems, INC. | $176.94 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $146.21 | 2023-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $110.01 | 2023-2025 | Eliquis, Camzyos |
| Cvrx, INC. | $105.20 | 2021-2024 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $103.94 | 2025 | Gore Cardioform Septal Occluder |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.46 | 2023-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.81 | 2019-2025 | Lifevest |
| Heartflow, INC. | $69.46 | 2023-2025 | Ffrct |
| Cardiovascular Systems INC. | $66.86 | 2019-2023 | Diamondback Coronary |
| Novartis Pharmaceuticals Corporation | $55.95 | 2021-2024 | |
| Livanova USA, INC. | $39.59 | 2025 | Tandemheart |
| Impulse Dynamics (USA) INC. | $39.19 | 2023 | Optimizer |
| Cardiva Medical, INC. | $34.16 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Philips North America LLC | $31.07 | 2025 | Igt Devices Undivided |
| Terumo Medical Corporation | $29.24 | 2019 | |
| Teleflex LLC | $28.31 | 2025 | Orsiro Mission |
| Angiodynamics, INC. | $23.28 | 2023 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.